Form preview

Get the free Vandetanib REMS Program - accessdata fda

Get Form
This document describes the Risk Evaluation and Mitigation Strategy (REMS) for vandetanib, a kinase inhibitor used in the treatment of medullary thyroid cancer. It outlines the goals of the REMS program,
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign vandetanib rems program

Edit
Edit your vandetanib rems program form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your vandetanib rems program form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing vandetanib rems program online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Here are the steps you need to follow to get started with our professional PDF editor:
1
Register the account. Begin by clicking Start Free Trial and create a profile if you are a new user.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit vandetanib rems program. Rearrange and rotate pages, add and edit text, and use additional tools. To save changes and return to your Dashboard, click Done. The Documents tab allows you to merge, divide, lock, or unlock files.
4
Get your file. When you find your file in the docs list, click on its name and choose how you want to save it. To get the PDF, you can save it, send an email with it, or move it to the cloud.
With pdfFiller, it's always easy to work with documents. Try it out!

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out vandetanib rems program

Illustration

How to fill out Vandetanib REMS Program

01
Step 1: Obtain the Vandetanib REMS Program enrollment form from the official website or your healthcare provider.
02
Step 2: Fill out the patient information section accurately with your personal details.
03
Step 3: Provide your healthcare provider's information, including their name, contact number, and address.
04
Step 4: Indicate the reason for enrollment, specifying that you are prescribed Vandetanib.
05
Step 5: Read and acknowledge the risks associated with Vandetanib treatment by signing the provided consent section.
06
Step 6: Submit the completed form to the REMS Program via the method specified on the form (fax, mail, or online submission).
07
Step 7: Confirm your enrollment status by contacting the REMS Program support line.

Who needs Vandetanib REMS Program?

01
Patients who have been prescribed Vandetanib for the treatment of medullary thyroid cancer or non-small cell lung cancer.
02
Healthcare providers who prescribe Vandetanib must ensure that patients are enrolled in the REMS Program.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.7
Satisfied
45 Votes

People Also Ask about

Vandetanib is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
HOW IS MTC TREATED? The primary treatment for MTC is surgery, and the currently accepted approach is to remove the entire thyroid gland (total thyroidectomy) (See thyroid surgery brochure). Often patients with MTC will have thyroid cancer present in the lymph nodes of the neck or upper chest.
On April 6, 2011, the U.S. Food and Drug Administration approved vandetanib (Caprelsa tablets; AstraZeneca Pharmaceuticals LP) for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease.
Vandetanib has a median plasma half-life of 19 days with steady state achieved at approximately 3 months.
The goals of the CAPRELSA REMS Program are to mitigate the serious risks of QT prolongation, Torsdes de pointes, and sudden death associated with use of CAPRELSA by: Educating prescribers on the following: Serious risks of QT prolongation,Torsades de pointes, and sudden death associated with use of CAPRELSA.
On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, as detected by an FDA-approved test, who

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

The Vandetanib REMS Program is a Risk Evaluation and Mitigation Strategy designed to ensure that the benefits of Vandetanib treatment outweigh its risks, particularly concerning the potential for serious adverse effects.
Healthcare providers who prescribe Vandetanib, as well as pharmacies that dispense it, are required to enroll in and comply with the Vandetanib REMS Program.
The Vandetanib REMS Program includes specific forms that must be completed by healthcare providers when prescribing the medication, which includes patient information and consent for treatment.
The purpose of the Vandetanib REMS Program is to mitigate the risks of serious side effects, including QT prolongation and thyroid dysfunction, associated with the use of the drug.
The information that must be reported includes patient demographics, treatment plan, monitoring results, and any adverse effects experienced by the patient while on Vandetanib.
Fill out your vandetanib rems program online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.